Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction

Circulation: Heart Failure

Volumn 8, Issue 4, 2015, Pages 757-765

  Tang, Xian Liang ^a   Rokosh, Gregg ^a   Sanganalmath, Santosh K ^a   Tokita, Yukichi ^a   Keith, Matthew C L ^a   Shirk, Gregg ^a   Stowers, Heather ^a   Hunt, Gregory N ^a   Wu, Wenjian ^a   Dawn, Buddhadeb ^b   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Left ventricular function; Myocardial infarction; Myocardial ischemia; Myocardial regeneration; Progenitor cells

Indexed keywords

BROXURIDINE; GREEN FLUORESCENT PROTEIN; BIOLOGICAL MARKER; STEM CELL FACTOR RECEPTOR;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRDU ASSAY; CARDIAC STEM CELL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXPERIMENTAL CORONARY OCCLUSION; EXPERIMENTAL MYOCARDIAL INFARCTION; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART PRELOAD; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; ADVERSE EFFECTS; ANGIOGENESIS; ANIMAL; CAPILLARY; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONVALESCENCE; DISEASE MODEL; ECHOGRAPHY; FISCHER 344 RAT; HEART OUTPUT; HEART VENTRICLE PRESSURE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; STEM CELL; TIME FACTOR; TISSUE SURVIVAL; TRANSPLANTATION;

ANIMALS; APOPTOSIS; BIOMARKERS; CAPILLARIES; CARDIAC OUTPUT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; RATS, INBRED F344; RECOVERY OF FUNCTION; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; TISSUE SURVIVAL; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84936979256     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.115.002210     Document Type: Article

References (30)

1. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
2. Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, Quijada P, Collins BL, Fransioli J, Sussman MA. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation. 2009;120:2077-2087. doi: 10.1161/CIRCULATIONAHA.109.884403.
3. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med. 2012;1:116-124. doi: 10.5966/sctm.2011-0015.
4. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, DAlessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007;104:14068-14073. doi: 10.1073/pnas.0706760104.
5. Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR. Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res. 2013;113:539-552. doi: 10.1161/CIRCRESAHA.113.301202.
6. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127:213-223. doi: 10.1161/CIRCULATIONAHA.112.131110.
7. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810-834. doi: 10.1161/CIRCRESAHA.113.300219.
8. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, Bolli R. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121:293-305. doi: 10.1161/CIRCULATIONAHA.109.871905.
9. Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, Torella D, Tang XL, Rezazadeh A, Kajstura J, Leri A, Hunt G, Varma J, Prabhu SD, Anversa P, Bolli R. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A. 2005;102:3766-3771. doi: 10.1073/pnas.0405957102.
10. Li Q, Guo Y, Ou Q, Chen N, Wu WJ, Yuan F, OBrien E, Wang T, Luo L, Hunt GN, Zhu X, Bolli R. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011;106:849-864. doi: 10.1007/s00395-011-0180-1.
11. Tang XL, Li Q, Rokosh DG, Chen N, Sanganalmath SK, Stowers H, Hunt G, Bolli R. The beneficial effects of cardiac stem cell therapy on left ventricular function and structure persists for at least one year in rats with acute myocardial infarction Circulation. 2012;126:A12248.
12. Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, Jneid H, Rota M, Leri A, Kajstura J. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013;128:122-131. doi: 10.1161/CIRCULATIONAHA.112.001075.
13. Bolli R, Chugh AR, DAmario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857. doi: 10.1016/S0140-6736(11)61590-0.
14. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012;126(11 suppl 1):S54-S64. doi: 10.1161/CIRCULATIONAHA.112.092627.
15. Rota M, Padin-Iruegas ME, Misao Y, De Angelis A, Maestroni S, Ferreira-Martins J, Fiumana E, Rastaldo R, Arcarese ML, Mitchell TS, Boni A, Bolli R, Urbanek K, Hosoda T, Anversa P, Leri A, Kajstura J. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008;103:107-116. doi: 10.1161/CIRCRESAHA.108.178525.
16. DAmario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, Hosoda T, Rota M, Connell JM, Gallegos RP, Welt FG, Givertz MM, Mitchell RN, Leri A, Kajstura J, Pfeffer MA, Anversa P. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res. 2011;108:857-861. doi: 10.1161/CIRCRESAHA.111.241380.
17. Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddard MF, Tang XL, Bolli R, Dawn B. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol. 2007;102:28-41. doi: 10.1007/s00395-006-0627-y.
18. Mohsin S, Khan M, Toko H, Bailey B, Cottage CT, Wallach K, Nag D, Lee A, Siddiqi S, Lan F, Fischer KM, Gude N, Quijada P, Avitabile D, Truffa S, Collins B, Dembitsky W, Wu JC, Sussman MA. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol. 2012;60:1278-1287. doi: 10.1016/j. jacc.2012.04.047.
19. Iso Y, Rao KS, Poole CN, Zaman AK, Curril I, Sobel BE, Kajstura J, Anversa P, Spees JL. Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction. Stem Cells. 2014;32:674-683. doi: 10.1002/stem.1546.
20. Kajstura J, Bai Y, Cappetta D, Kim J, Arranto C, Sanada F, DAmario D, Matsuda A, Bardelli S, Ferreira-Martins J, Hosoda T, Leri A, Rota M, Loscalzo J, Anversa P. Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res. 2012;111:894-906. doi: 10.1161/CIRCRESAHA.112.273649.
21. Padin-Iruegas ME, Misao Y, Davis ME, Segers VF, Esposito G, Tokunou T, Urbanek K, Hosoda T, Rota M, Anversa P, Leri A, Lee RT, Kajstura J. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009;120:876-887. doi: 10.1161/CIRCULATIONAHA.109.852285.
22. Molgat AS, Tilokee EL, Rafatian G, Vulesevic B, Ruel M, Milne R, Suuronen EJ, Davis DR. Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity. Circulation. 2014;130(11 suppl 1):S70-S76. doi: 10.1161/CIRCULATIONAHA.113.007908.
23. Zhang LX, DeNicola M, Qin X, Du J, Ma J, Tina Zhao Y, Zhuang S, Liu PY, Wei L, Qin G, Tang Y, Zhao TC. Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs. Am J Physiol Cell Physiol. 2014;307:C358-C372. doi: 10.1152/ajpcell.00187.2013.
24. Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58:1095-1104. doi: 10.1016/j.jacc.2011.06.016.
25. Dib N, Khawaja H, Varner S, McCarthy M, Campbell A. Cell therapy for cardiovascular disease: a comparison of methods of delivery. J Cardiovasc Transl Res. 2011;4:177-181. doi: 10.1007/s12265-010-9253-z.
26. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113:1311-1325. doi: 10.1161/CIRCULATIONAHA.105.541268.
27. Shim WS, Tan G, Gu Y, Qian L, Li S, Chung YY, Lim SY, Sim E, Chuah SC, Wong P. Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function. J Heart Lung Transplant. 2010;29:1415-1426. doi: 10.1016/j.healun.2010.06.009.
28. Shen D, Cheng K, Marbn E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med. 2012;16:2112-2116. doi: 10.1111/j.1582-4934.2011.01512.x.
29. Wolf D, Reinhard A, Seckinger A, Katus HA, Kuecherer H, Hansen A. Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart. Stem Cells Dev. 2009;18:321-329. doi: 10.1089/scd.2008.0019.
30. Dawkins J, Gallet R, Kreke M, Smith R, Middleton R, J. V, Cingolani E, Kar S, Marban L, Makkar R, Marban E. Dose-escalation study using novel continuous flow intracoronary delivery of allogeneic cardiospherederviced stem cells: Is there a threshold for cell therapy? Circulation. 2014;130:A16451 (Abstract).